You are here

BIOTEK, INC.

Company Information
Address
21-C OLYMPIA AVENUE
WOBURN, MA 01801
United States



Information

UEI: N/A

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. PRODUCTION OF POLYCLONAL ANTIBODIES IN RABBITS

    Amount: $49,903.00

    N/A

    SBIRPhase I1992Department of Defense Army
  2. SUSTAINED-ACTION BUPRENORPHINE

    Amount: $489,791.00

    BUPRENORPHINE HAS BEEN SHOWN TO SUPPRESS HEROIN USE BY ADDICTS, AND STUDIES INDICATE THAT IT MAY BE A USEFUL TREATMENT FOR OPIOID DEPENDENCE. THIS PARTIAL AGONIST-ANTAGONIST COMBINES THE ADVANTAGES OF ...

    SBIRPhase II1991Department of Health and Human Services
  3. AN ESTROGEN-PROGESTIN PATCH FOR ESTROGEN REPLACEMENT

    Amount: $47,824.00

    N/A

    SBIRPhase I1991Department of Health and Human Services
  4. SUPPOSITORIES FOR RAPID ANTI-EPILEPTIC DIAZEPAM DELIVERY

    Amount: $49,982.00

    N/A

    SBIRPhase I1991Department of Health and Human Services
  5. DEVELOPMENT AND TESTING OF NEW SPERMICIDE SUPPOSITORY

    Amount: $50,000.00

    N/A

    SBIRPhase I1991Department of Health and Human Services
  6. ONE WEEK SUSTAINED RELEASE METHADONE MICROCAPSULES

    Amount: $489,927.00

    THE OVERALL OBJECTIVE OF THE PROJECT IS TO DEVELOP SUSTAINED ACTION INJECTABLE BIODEGRADABLE L-METHADONE MICROCAPSULES WHICH WILL MAINTAIN PLASMA LEVELS OF 200 NG/ML FOR ONE WEEK. PHASE I SBIR SUPPORT ...

    SBIRPhase II1990Department of Health and Human Services
  7. SUSTAINED-ACTION BUPRENORPHINE

    Amount: $49,289.00

    N/A

    SBIRPhase I1990Department of Health and Human Services
  8. TRANSDERMAL NICOTINE-AN AID TO SMOKING CESSATION

    Amount: $476,900.00

    NICOTINE SUBSTITUTION OR MAINTENANCE HAS BEEN SHOWN TO BE ANEFFECTIVE AID FOR CEASING SMOKING. THE OVERALL GOAL OF THIS PROGRAM IS TO DEVELOP A TRANSDERMAL NICOTINE DELIVERY SYSTEM AS AN AID TO CESSAT ...

    SBIRPhase II1989Department of Health and Human Services
  9. SUSTAINED-ACTION NALMEFENE

    Amount: $492,300.00

    NALMEFENE HAS BEEN SHOWN TO BE AN EFFECTIVE PHARMACOLOGICAL INTERVENTION FOR PROTECTING POSTADDICTS FROM RE-ADDICTION. WITH THIS MODALITY, IN CONTRAST TO METHADONE, THE PATIENT ISFREE OF OPIOIDS. THE ...

    SBIRPhase II1989Department of Health and Human Services
  10. HEAT-ACTIVATED MICROPARTICLE DRUG DELIVERY SYSTEMS

    Amount: $50,000.00

    THE OVERALL OBJECTIVE OF THE PROJECT IS TO DEVELOP HEAT-ACTIVATED MICROPARTICLE DRUG DELIVERY SYSTEMS FOR DELIVERY OF CHEMOTHERAPEUTIC AGENTS THAT COULD BE USED IN CONJUNCTION WITH THERAPEUTIC HYPERTH ...

    SBIRPhase I1989Department of Health and Human Services
US Flag An Official Website of the United States Government